2-26187671-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001168241.2(GAREM2):c.2039C>A(p.Pro680His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000122 in 1,517,704 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001168241.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GAREM2 | NM_001168241.2 | c.2039C>A | p.Pro680His | missense_variant | 6/6 | ENST00000401533.7 | NP_001161713.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAREM2 | ENST00000401533.7 | c.2039C>A | p.Pro680His | missense_variant | 6/6 | 1 | NM_001168241.2 | ENSP00000384593 | P1 | |
GAREM2 | ENST00000407684.1 | c.1453-44C>A | intron_variant | 2 | ENSP00000384581 |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152164Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000154 AC: 19AN: 123170Hom.: 0 AF XY: 0.000108 AC XY: 7AN XY: 65032
GnomAD4 exome AF: 0.0000850 AC: 116AN: 1365422Hom.: 0 Cov.: 32 AF XY: 0.0000730 AC XY: 49AN XY: 671066
GnomAD4 genome AF: 0.000453 AC: 69AN: 152282Hom.: 0 Cov.: 33 AF XY: 0.000497 AC XY: 37AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2021 | The c.2039C>A (p.P680H) alteration is located in exon 6 (coding exon 6) of the GAREM2 gene. This alteration results from a C to A substitution at nucleotide position 2039, causing the proline (P) at amino acid position 680 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at